Select plasma oxylipins as potential biomarkers of effective indomethacin treatment response in preterm infants with patent ductus arteriosus

Khanh C. K. Nguyen, Cindy H. T. Yeung, Allison Scott, Thomas J. Velenosi, Tamorah Lewis · 2026

Read Select plasma oxylipins as potential biomarkers of effective indomethacin treatment response in preterm infants with patent ductus arteriosus by Khanh C. K. Nguyen, Cindy H. T. Yeung, Allison Scott, Thomas J. Velenosi, Tamorah Lewis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13427838.txt.

Description

Khanh Nguyen and colleagues hunted for blood markers that predict whether a heart drug will work in premature babies. The babies had a patent ductus arteriosus, a blood vessel that stays open after birth and strains the heart and lungs.

Seventeen babies born before 34 weeks received indomethacin, a drug meant to close the vessel, and gave blood and urine samples. Twelve babies responded to the drug and five did not. Before treatment, four fat-like signals called oxylipins ran higher in the blood of babies who went on to respond. Those signals fell after treatment in responders but stayed flat in non-responders, hinting at a future test to guide dosing.

Catalog record

CREATORKhanh C. K. Nguyen, Cindy H. T. Yeung, Allison Scott, Thomas J. Velenosi, Tamorah Lewis
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13427838

Browse the full library · About the Tower of Babel